ADVANCED NSCLC

Clinical trials for ADVANCED NSCLC explained in plain language.

Never miss a new study

Get alerted when new ADVANCED NSCLC trials appear

Sign up with your email to follow new studies for ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

Lung cancer drug trial pulled before it even started

Disease control Terminated

This study was designed to test the safety and effectiveness of ningetinib (CT053PTSA) in people with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change called MET exon 14 skipping. It planned to enroll adults aged 18-75 with stage IIIB-IV cancer. Howe…

Matched conditions: ADVANCED NSCLC

Phase: PHASE2 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control

Last updated May 17, 2026 06:14 UTC

ADVANCED NSCLC

Get alerted when new ADVANCED NSCLC trials appear

Lung cancer drug trial pulled before it even started